SAba Sile
Corporate Officer/Principal presso SPRUCE BIOSCIENCES, INC.
Posizioni attive di SAba Sile
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SPRUCE BIOSCIENCES, INC. | Corporate Officer/Principal | 10/11/2022 | - |
Storia della carriera di SAba Sile
Precedenti posizioni note di SAba Sile
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | - | - |
| BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | - | - |
Formazione di SAba Sile
| University of Pittsburgh School of Medicine | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
| Irlanda | 2 |
Posizioni
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| SPRUCE BIOSCIENCES, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
- Borsa valori
- Insiders
- SAba Sile
- Esperienza
